Available Technology
Our commercialisation experts can connect you with intellectual property from the world-class researchers at the ³ÉÈË´óƬ. We have a range of technologies available for licensing and investment.
We are committed to engaging and partnering with industry in the translation of our research to create economic, environmental and social benefits both in Australia and globally and this is reflected in our Intellectual Property Principles.
The following provides a sample of our available technologies. Please contact our Commercialisation team to discuss our full range of projects.Ìý
Automated hip implant loosening detection system
A system for early and accurate detection of hip implant loosening to reduce surgical revision rates.
Commercial contact:ÌýAisha Sirop
Ìý
Sperm Sorter for IVF
Selecting the best sperm, the way nature does.
Commercial contact:ÌýAnne Donaldson
Cell-Sensitive Elastography Imaging
A new elastography imaging model with cellullar-level resolution.
Commercial contact: Aisha Sirop
Bioharvesting of wool
A new approach to replace traditional shearing by creating a weak point inÌýthe wool fibre allowing for mechanical harvesting.
Commercial contact:ÌýCathryn Lee
IMAGENDO
Non-invasive diagnosis of endometriosis with imaging and artificial intelligence
Commercial contact: Aisha Sirop
Superconducting magnetic sensor
A next-generation high-sensitivity and high-resolution superconductingÌýmagnetic sensor for medical applications.
Commercial contact:ÌýAisha Sirop
Automated Cardiac Beat-to-Beat Variability Monitoring
A fully automated ECG processing technologyÌýthat also includes conventional fiducial waveÌýdelineation, providing unprecedented accuracy in beat-to-beatÌýmeasurement of the QT interval,Ìýsignificantly outperformingÌýexisting methods.
Commercial contact:ÌýAisha Sirop
Hybrid Imaging Catheter
A new multi-modal optical coherence tomography (OCT) and autofluorescence imaging technology.
Commercial contact:ÌýAisha Sirop
Zinc Acid Manganese Battery
A zinc acid manganese (ZAM) battery that has more than double the energy density of comparable batteries.
Commercial contact: Gerard LaFontaine
Apicomplexan Vaccine
A non-live vaccine for the prevention of Apicomplexan parasitic diseases and pathogens.
Commercial contact:ÌýFrancois Duvenage
Antiviral Agents
A proposal to screen several naturally occuring nucleoside analogues and their derivatives for antiviral activity.
Commercial contact: Commercialisation
Novel Antibiotics Based on Biotin Protein Ligase Inhibition
A new antibiotic that successfully targets infections based on Biotin Protein Ligase (BPL) inhibition.
Commercial contact: Commercialisation
Hydrogen-Bonded Organic Frameworks as Protective Coatings for Biomolecules
A purely organic, chrystalline matrix that can encapsulate, protect and preserve bio-molecules such as proteins, vaccines and enzymes.
Commercial contact:ÌýCommercialisation
New Australian Psyllium
An all-naturalÌýgelling agent for use in gluten-free processed food markets as a next generation dietary fibre.
Commercial contact: Cathryn Lee
Method & System to Detect Orbiting Objects
Robust foregroundÌýsegmentation and imageÌýregistration for opticalÌýdetection of objects inÌýgeostationary orbit.
Commercial contact:ÌýFrancois Duvenage
Contact us
To be connected with one of our Commercial Managers contact usÌýon:
T: +61 8 8313 4403 orÌýE:Ìýcommercialisation@adelaide.edu.au